VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Suzhou CTI Bio Supports Chengdu Tetrahedron's THM401 IND Approval for Drug-Resistant Gram-Negative Infections
Suzhou CTI Bio Supports Chengdu Tetrahedron's THM401 IND Approval for Drug-Resistant Gram-Negative Infections
May 20, 2026 13:09 CST Updated 15:26
Share:
